Journals / Eurasian Journal of Medicine / 2019 / Cilt: 51 - Sayı: 1

The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers

Pages
8–11
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The preoperative TSH level can be considered for the probability of preoperative metastases and can contribute to plan the extent of surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Thyroid-stimulating hormone/thyrotropin (TSH) is known to induce malignancies and tissue growth of the thyroid gland.
📊
Key Findings & Data:The aim of the present study was to evaluate the relationship between highly risky clinicopathological factors with preoperative high levels of TSH.Materials and Methods: The records of 89 patients (67 females and 22 males) who underwent surgery for differentiated thyroid cancer between 2011 and 2013 were reviewed.
💡
Conclusion & Impact:The preoperative TSH level can be considered for the probability of preoperative metastases and can contribute to plan the extent of surgery.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Thyroid-stimulating hormone/thyrotropin (TSH) is known to induce malignancies and tissue growth of the thyroid gland. While the relationship of higher levels of TSH with advanced stages of cancer had been published in previous studies, the relationship of the tumor with the clinicopathological factors had not been completely evaluated. The aim of the present study was to evaluate the relationship between highly risky clinicopathological factors with preoperative high levels of TSH.Materials and Methods: The records of 89 patients (67 females and 22 males) who underwent surgery for differentiated thyroid cancer between 2011 and 2013 were reviewed. The relationship of preoperative TSH between tumor size, multicentricity, lymphovascular invasion, extrathyroidal extension, central neck metastasis, and lateral neck metastasis was evaluated.Results: The preoperative TSH levels were high in patients with multicentricity (p=0.022), lymphovascular invasion (p=0.018), and central neck metastasis (p=0.002). The prevalence of extrathyroidal extension (p=0.41), lymphovascular invasion (p=0.020), and central metastasis (p=0.009) was significantly high in patients with a TSH level ≥2.5 mIU/L. The preoperative TSH levels were determined as an independent predictive risk factor for central neck metastases (p=0.012) and extrathyroidal extension (p=0.041) in multinomial logistical regression analysis.Conclusion: The power of radiological imaging for the identification of central neck metastases in preoperative evaluation is limited. The preoperative high level of TSH is an independent predictive factor for central metastases and extrathyroidal extension. It can help to predict tumor staging. Furthermore, related with multicentricity and lymphovascular invasion, it can affect the high risk characteristics of the tumor except the stage. The preoperative TSH level can be considered for the probability of preoperative metastases and can contribute to plan the extent of surgery.

🔖

Cite This Article

BESLER, E., CİTGEZ, B., AYGÜN, N., CELAYİR, M. F., MİHMANLI, M., YETKİN, S. G., ULUDAĞ, M., ÖZGÜVEN, M. B. Y. (2022). The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers. Eurasian Journal of Medicine, Cilt: 51 - Sayı: 1, 8–11. https://ajindex.com/articles/508934

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009
  2. Rosário PW, Ward LS, Carvalho GA, et al. Thyroid nodules and differantiated thyroid cancer: update on the Brazilian consensus. Arq Bras Endocrinol Metabol 2013; 57: 240-64. [CrossRef] 3. Kim D, Park JW. Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s). J Korean Surg Soc 2013; 85: 15-9. [CrossRef] 4. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295-301. [CrossRef] 5. Jonklaas J, Nsouli-Maktabi H, Soldin SJ. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 2008; 18: 943-52. [CrossRef] 6. Polyzos SA, Kappaita M, Efstathiadou Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 2008; 134: 953-60. [CrossRef] 7. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008; 93: 809-14. [CrossRef] 8. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009; 71: 434-39. [CrossRef] 9. Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009; 16: 1251-60. [CrossRef] 10. Jin J, Machekano R, McHenry CR. The utility of preoperative serum thyroid- stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg 2010; 199: 294-7. [CrossRef] 11. Fiore E, Rago T, Provenzale MA, et al. L –thyroxine treated patients with nodular goiter have lower serum TSH and lower frequency of papillarythyroid cancer: results of a cross-sectional study on 27,914 patients. Endocr Relat Cancer 2010; 17: 231-9. [CrossRef] 12. Zeng Q, Liu J, Zhu J, Hu G. Association between preoperative serum thyroid-stimulating hormone level and nonfunctioning mali